Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of Intercell's Japanese encephalitis vaccine, IC 51, compared with a mouse-brain Japanese encephalitis vaccine, for the prevention of encephalitis virus infections in paediatric patients in India.

Next Previous
Trial Profile

Phase II trial of Intercell's Japanese encephalitis vaccine, IC 51, compared with a mouse-brain Japanese encephalitis vaccine, for the prevention of encephalitis virus infections in paediatric patients in India.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 23 Dec 2009

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs IC 51 (Primary) ; Aluminium hydroxide; Japanese encephalitis vaccine
  • Indications Encephalitis virus infections; Japanese encephalitis
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Biological E Limited; Intercell

Most Recent Events

  • 08 Jan 2010 Results reported in Vaccine.
  • 10 Dec 2008 Results data presented at the American Society for Tropical Medicine and Hygiene Annual Meeting (ASTMH) 2008, as reported in a media release from Intercell.
  • 15 Apr 2008 Preliminary results available, according to an Intercell media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top